[Nirmatrelvir/ritonavir (Paxlovid®), a treatment for Covid-19]. / Le nirmatrelvir-ritonavir (Paxlovid®), un traitement contre la Covid-19.
Actual Pharm
; 61(617): 10-12, 2022 Jun.
Article
en Fr
| MEDLINE
| ID: mdl-35891982
ABSTRACT
The nirmatrelvir-ritonavir (Paxlovid®) is a treatment against Covid-19 available in pharmacies since February 4, 2022. Administered orally, it is intended only for people at very high risk of contracting one or more severe forms of the disease.
Texto completo:
1
Bases de datos:
MEDLINE
Idioma:
Fr
Revista:
Actual Pharm
Año:
2022
Tipo del documento:
Article
País de afiliación:
Francia